JP2014524465A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014524465A5 JP2014524465A5 JP2014526601A JP2014526601A JP2014524465A5 JP 2014524465 A5 JP2014524465 A5 JP 2014524465A5 JP 2014526601 A JP2014526601 A JP 2014526601A JP 2014526601 A JP2014526601 A JP 2014526601A JP 2014524465 A5 JP2014524465 A5 JP 2014524465A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- group
- bacteriochlorophyll
- nrr
- oxo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 bacteriochlorophyll compound Chemical class 0.000 claims 35
- 108010003118 Bacteriochlorophylls Proteins 0.000 claims 19
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims 19
- 229930002875 chlorophyll Natural products 0.000 claims 12
- 235000019804 chlorophyll Nutrition 0.000 claims 12
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 11
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 9
- DSJXIQQMORJERS-AGGZHOMASA-M bacteriochlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC([C@H](CC)[C@H]3C)=[N+]4C3=CC3=C(C(C)=O)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 DSJXIQQMORJERS-AGGZHOMASA-M 0.000 claims 8
- 150000001768 cations Chemical class 0.000 claims 8
- 229910052760 oxygen Inorganic materials 0.000 claims 8
- 229910052763 palladium Inorganic materials 0.000 claims 8
- 230000004962 physiological condition Effects 0.000 claims 6
- 229910052717 sulfur Inorganic materials 0.000 claims 6
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical class C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 claims 5
- 125000000623 heterocyclic group Chemical group 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 125000005842 heteroatom Chemical group 0.000 claims 4
- 230000002378 acidificating effect Effects 0.000 claims 3
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims 3
- 150000001408 amides Chemical class 0.000 claims 3
- 150000001413 amino acids Chemical class 0.000 claims 3
- 150000004036 bacteriochlorins Chemical class 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- 125000000524 functional group Chemical group 0.000 claims 3
- 150000004676 glycans Chemical class 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 238000002428 photodynamic therapy Methods 0.000 claims 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 229920006395 saturated elastomer Polymers 0.000 claims 3
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical group C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 2
- 239000003513 alkali Substances 0.000 claims 2
- 150000001447 alkali salts Chemical class 0.000 claims 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims 2
- 150000001450 anions Chemical class 0.000 claims 2
- 229920001222 biopolymer Polymers 0.000 claims 2
- 125000002837 carbocyclic group Chemical group 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 210000004087 cornea Anatomy 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 229910052751 metal Inorganic materials 0.000 claims 2
- 239000002184 metal Substances 0.000 claims 2
- 150000002772 monosaccharides Chemical class 0.000 claims 2
- 229920001542 oligosaccharide Polymers 0.000 claims 2
- 150000002482 oligosaccharides Chemical class 0.000 claims 2
- 150000002892 organic cations Chemical class 0.000 claims 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims 2
- 108010013121 palladium-bacteriopheophorbide Proteins 0.000 claims 2
- 229920001282 polysaccharide Polymers 0.000 claims 2
- 239000005017 polysaccharide Substances 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 210000003786 sclera Anatomy 0.000 claims 2
- 125000004642 (C1-C12) alkoxy group Chemical group 0.000 claims 1
- 125000004530 1,2,4-triazinyl group Chemical group N1=NC(=NC=C1)* 0.000 claims 1
- JIHQDMXYYFUGFV-UHFFFAOYSA-N 1,3,5-triazine Chemical compound C1=NC=NC=N1 JIHQDMXYYFUGFV-UHFFFAOYSA-N 0.000 claims 1
- 125000003363 1,3,5-triazinyl group Chemical group N1=C(N=CN=C1)* 0.000 claims 1
- FEBUJFMRSBAMES-UHFFFAOYSA-N 2-[(2-{[3,5-dihydroxy-2-(hydroxymethyl)-6-phosphanyloxan-4-yl]oxy}-3,5-dihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-4-yl)oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl phosphinite Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(OC2C(C(OP)C(O)C(CO)O2)O)C(O)C(OC2C(C(CO)OC(P)C2O)O)O1 FEBUJFMRSBAMES-UHFFFAOYSA-N 0.000 claims 1
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 claims 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 claims 1
- 206010054760 Corneal thinning Diseases 0.000 claims 1
- 229920002307 Dextran Polymers 0.000 claims 1
- 239000004593 Epoxy Substances 0.000 claims 1
- 229910052688 Gadolinium Inorganic materials 0.000 claims 1
- 229920002148 Gellan gum Polymers 0.000 claims 1
- 229920002907 Guar gum Polymers 0.000 claims 1
- RAXXELZNTBOGNW-UHFFFAOYSA-O Imidazolium Chemical compound C1=C[NH+]=CN1 RAXXELZNTBOGNW-UHFFFAOYSA-O 0.000 claims 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-O Pyrazolium Chemical compound C1=CN[NH+]=C1 WTKZEGDFNFYCGP-UHFFFAOYSA-O 0.000 claims 1
- 229920002305 Schizophyllan Polymers 0.000 claims 1
- 229910052769 Ytterbium Inorganic materials 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims 1
- VUEDNLCYHKSELL-UHFFFAOYSA-N arsonium Chemical compound [AsH4+] VUEDNLCYHKSELL-UHFFFAOYSA-N 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- XYOVOXDWRFGKEX-UHFFFAOYSA-N azepine Chemical group N1C=CC=CC=C1 XYOVOXDWRFGKEX-UHFFFAOYSA-N 0.000 claims 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 229940125904 compound 1 Drugs 0.000 claims 1
- 229940125782 compound 2 Drugs 0.000 claims 1
- 229940126214 compound 3 Drugs 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 1
- 239000000216 gellan gum Substances 0.000 claims 1
- 235000010492 gellan gum Nutrition 0.000 claims 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-O guanidinium Chemical compound NC(N)=[NH2+] ZRALSGWEFCBTJO-UHFFFAOYSA-O 0.000 claims 1
- 239000000665 guar gum Substances 0.000 claims 1
- 235000010417 guar gum Nutrition 0.000 claims 1
- 229960002154 guar gum Drugs 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-O hydron;1,3-oxazole Chemical compound C1=COC=[NH+]1 ZCQWOFVYLHDMMC-UHFFFAOYSA-O 0.000 claims 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-O hydron;pyrimidine Chemical compound C1=CN=C[NH+]=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-O 0.000 claims 1
- SMWDFEZZVXVKRB-UHFFFAOYSA-O hydron;quinoline Chemical compound [NH+]1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-O 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 125000002883 imidazolyl group Chemical group 0.000 claims 1
- 229910052738 indium Inorganic materials 0.000 claims 1
- AWJUIBRHMBBTKR-UHFFFAOYSA-O isoquinolin-2-ium Chemical compound C1=[NH+]C=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-O 0.000 claims 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 229920000609 methyl cellulose Polymers 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000001923 methylcellulose Substances 0.000 claims 1
- 235000010981 methylcellulose Nutrition 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 230000003287 optical effect Effects 0.000 claims 1
- 125000002971 oxazolyl group Chemical group 0.000 claims 1
- 125000004043 oxo group Chemical group O=* 0.000 claims 1
- 108010049593 padeliporfin Proteins 0.000 claims 1
- 230000035515 penetration Effects 0.000 claims 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 claims 1
- 229910052697 platinum Inorganic materials 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 150000004804 polysaccharides Polymers 0.000 claims 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 claims 1
- 125000003226 pyrazolyl group Chemical group 0.000 claims 1
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 1
- SBMSLRMNBSMKQC-UHFFFAOYSA-N pyrrolidin-1-amine Chemical group NN1CCCC1 SBMSLRMNBSMKQC-UHFFFAOYSA-N 0.000 claims 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 1
- RWSOTUBLDIXVET-UHFFFAOYSA-O sulfonium Chemical compound [SH3+] RWSOTUBLDIXVET-UHFFFAOYSA-O 0.000 claims 1
- 125000004434 sulfur atom Chemical group 0.000 claims 1
- 125000000335 thiazolyl group Chemical group 0.000 claims 1
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical group C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- 229910052725 zinc Inorganic materials 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161526414P | 2011-08-23 | 2011-08-23 | |
| US61/526,414 | 2011-08-23 | ||
| PCT/IL2012/050325 WO2013027222A1 (en) | 2011-08-23 | 2012-08-23 | (bacterio)chlorophyll photosensitizers for treatment of eye diseases and disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014524465A JP2014524465A (ja) | 2014-09-22 |
| JP2014524465A5 true JP2014524465A5 (https=) | 2015-10-01 |
| JP6215203B2 JP6215203B2 (ja) | 2017-10-18 |
Family
ID=46889394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014526601A Active JP6215203B2 (ja) | 2011-08-23 | 2012-08-23 | 眼疾患および障害の治療用の（バクテリオ）クロロフィル光増感剤 |
Country Status (20)
| Country | Link |
|---|---|
| US (4) | US9452172B2 (https=) |
| EP (1) | EP2747763B1 (https=) |
| JP (1) | JP6215203B2 (https=) |
| KR (1) | KR101962991B1 (https=) |
| CN (1) | CN103930108B (https=) |
| AU (1) | AU2012298156B2 (https=) |
| BR (1) | BR112014004306A2 (https=) |
| CA (1) | CA2846011C (https=) |
| CL (1) | CL2014000432A1 (https=) |
| DK (1) | DK2747763T3 (https=) |
| ES (1) | ES2856698T3 (https=) |
| HK (1) | HK1199412A1 (https=) |
| HU (1) | HUE053321T2 (https=) |
| IN (1) | IN2014CN02153A (https=) |
| MX (1) | MX360683B (https=) |
| PE (1) | PE20141183A1 (https=) |
| PT (1) | PT2747763T (https=) |
| RU (1) | RU2632439C2 (https=) |
| WO (1) | WO2013027222A1 (https=) |
| ZA (1) | ZA201402056B (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9622911B2 (en) | 2010-09-30 | 2017-04-18 | Cxl Ophthalmics, Llc | Ophthalmic treatment device, system, and method of use |
| WO2013009701A2 (en) | 2011-07-08 | 2013-01-17 | The University Of North Carolina At Chapel Hill | Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders |
| WO2013149075A1 (en) | 2012-03-29 | 2013-10-03 | Cxl Ophthalmics, Llc | Compositions and methods for treating or preventing diseases associated with oxidative stress |
| EP4420725A3 (en) | 2012-03-29 | 2025-04-16 | Epion Therapeutics, Inc. | Ocular treatment solutions, delivery devices and delivery augmentation methods |
| RU2635185C2 (ru) * | 2013-12-17 | 2017-11-09 | Иван Дмитриевич Захаров | Фармацевтический препарат для профилактики и лечения прогрессирующей близорукости |
| US11207410B2 (en) | 2015-07-21 | 2021-12-28 | Avedro, Inc. | Systems and methods for treatments of an eye with a photosensitizer |
| CN106620893B (zh) | 2015-07-23 | 2021-07-30 | 爱博诺德(北京)医疗科技股份有限公司 | 用于眼部疾病光治疗的材料 |
| US10449090B2 (en) | 2015-07-31 | 2019-10-22 | Allotex, Inc. | Corneal implant systems and methods |
| CN105601638B (zh) * | 2016-01-28 | 2018-10-26 | 东北林业大学 | 一种叶绿酸衍生物及其制备方法、作为光敏抑菌剂及光敏杀虫剂的应用 |
| WO2017180851A1 (en) | 2016-04-13 | 2017-10-19 | Avedro, Inc. | Systems and methods for delivering drugs to an eye |
| WO2017193019A1 (en) * | 2016-05-05 | 2017-11-09 | David Muller | Corneal implant systems and methods |
| AU2017390276A1 (en) * | 2017-01-03 | 2019-06-27 | Vitrean, Inc. | Methods and devices for treating a retinal detachment |
| EP3638367A4 (en) | 2017-08-02 | 2021-07-21 | The University of Chicago | NANOMETRIC ORGANOMETALLIC AND NANOPLAQUE ORGANOMETALLIC LAYERS FOR X-RAY INDUCED PHOTODYNAMIC THERAPY, RADIOTHERAPY, RADIODYNAMIC THERAPY, CHEMOTHERAPY, IMMUNOTHERAPY, AND ANY COMBINATION OF THESE |
| CN109091685A (zh) * | 2018-08-10 | 2018-12-28 | 北京市眼科研究所 | 一种对角膜炎提取细菌病原体的灭活方法 |
| SG11202103215SA (en) * | 2018-10-24 | 2021-05-28 | California Inst Of Techn | Treatment of myopia and other ocular conditions using singlet oxygen |
| US11702546B2 (en) | 2018-10-24 | 2023-07-18 | California Institute Of Technology | Near-infrared heptamethine dyes for generation of singlet oxygen |
| US20220041563A1 (en) * | 2018-12-04 | 2022-02-10 | Avedro, Inc. | Compounds and Compositions for Eye Treatments |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL102645A (en) | 1992-07-26 | 1998-02-22 | Yeda Res & Dev | Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
| US5756541A (en) * | 1996-03-11 | 1998-05-26 | Qlt Phototherapeutics Inc | Vision through photodynamic therapy of the eye |
| IL133253A0 (en) * | 1999-12-01 | 2001-04-30 | Yeda Res & Dev | Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them |
| RU2201219C2 (ru) * | 2001-04-24 | 2003-03-27 | Макаров Константин Алексеевич | Фармакологическая композиция пролонгированного действия |
| AU2002336636A1 (en) * | 2001-10-03 | 2003-04-14 | Miravant Pharmaceuticals, Inc. | Photosensitizing carbamate derivatives |
| IL152900A0 (en) * | 2002-11-17 | 2003-06-24 | Yeda Res & Dev | Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses |
| DK1753457T3 (en) * | 2004-06-07 | 2016-12-05 | Yeda Res & Dev | Cationic bakterieklorofylderivater and uses |
| RU2450018C2 (ru) * | 2006-08-23 | 2012-05-10 | Йеда Рисерч Энд Диверлопмент Ко. Лтд | Конъюгаты rgd-пептидов и фотосенсибилизаторов порфирина или (бактерио)хлорофилла и их применение |
| WO2008052081A2 (en) | 2006-10-24 | 2008-05-02 | California Institute Of Technology | Photochemical therapy to affect mechanical and/or chemical properties of body tissue |
| RU2404768C1 (ru) * | 2009-10-28 | 2010-11-27 | Федеральное агентство по науке и инновациям | Глазные капли |
| WO2011099602A1 (ja) * | 2010-02-12 | 2011-08-18 | 学校法人日本大学 | ポルフィリン誘導体および放射線力学療法におけるその使用 |
-
2012
- 2012-08-23 IN IN2153CHN2014 patent/IN2014CN02153A/en unknown
- 2012-08-23 CN CN201280045801.9A patent/CN103930108B/zh active Active
- 2012-08-23 RU RU2014110784A patent/RU2632439C2/ru active
- 2012-08-23 HK HK14113090.6A patent/HK1199412A1/xx unknown
- 2012-08-23 MX MX2014002107A patent/MX360683B/es active IP Right Grant
- 2012-08-23 HU HUE12762405A patent/HUE053321T2/hu unknown
- 2012-08-23 US US14/240,328 patent/US9452172B2/en active Active
- 2012-08-23 DK DK12762405.4T patent/DK2747763T3/da active
- 2012-08-23 AU AU2012298156A patent/AU2012298156B2/en not_active Ceased
- 2012-08-23 PE PE2014000246A patent/PE20141183A1/es not_active Application Discontinuation
- 2012-08-23 CA CA2846011A patent/CA2846011C/en active Active
- 2012-08-23 ES ES12762405T patent/ES2856698T3/es active Active
- 2012-08-23 BR BR112014004306A patent/BR112014004306A2/pt not_active IP Right Cessation
- 2012-08-23 EP EP12762405.4A patent/EP2747763B1/en active Active
- 2012-08-23 WO PCT/IL2012/050325 patent/WO2013027222A1/en not_active Ceased
- 2012-08-23 KR KR1020147007481A patent/KR101962991B1/ko active Active
- 2012-08-23 JP JP2014526601A patent/JP6215203B2/ja active Active
- 2012-08-23 PT PT127624054T patent/PT2747763T/pt unknown
-
2014
- 2014-02-21 CL CL2014000432A patent/CL2014000432A1/es unknown
- 2014-03-20 ZA ZA2014/02056A patent/ZA201402056B/en unknown
-
2016
- 2016-08-18 US US15/240,221 patent/US20160354468A1/en not_active Abandoned
-
2018
- 2018-11-20 US US16/196,537 patent/US11058772B2/en active Active
-
2021
- 2021-07-08 US US17/370,743 patent/US20210330792A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014524465A5 (https=) | ||
| RU2014110784A (ru) | Фотосенсибилизаторы на основе (бактерио)хлорофилла для лечения глазных заболеваний и расстройств | |
| JP7532259B2 (ja) | 眼疾患治療薬剤 | |
| PT1968594E (pt) | Tratamento de distúrbios neovasculares oculares tais como degeneração macular, estrias angióides, uveite e edema macular | |
| JP4106232B2 (ja) | 医薬組成物 | |
| CN103249400B (zh) | 用于治疗青光眼和高眼压症的腺苷a1激动剂 | |
| WO2013077579A1 (ko) | 안과 질환의 예방 및 치료용 약학 조성물 | |
| JP2008501780A5 (https=) | ||
| WO2006132342A1 (ja) | ロフルミラスト点眼液 | |
| RU2006146677A (ru) | Катионные производные бактериохлорофилла и их применение | |
| RU2706353C1 (ru) | Новая офтальмологическая композиция, содержащая ребамипид, и способ ее получения | |
| RU2010149312A (ru) | ТЕРАПЕВТИЧЕСКИ ПОЛЕЗНЫЕ ЗАМЕЩЕННЫЕ ГИДРОПИРИДО [3,2,1-ij] ХИНОЛИНОВЫЕ СОЕДИНЕНИЯ | |
| CN107660198B (zh) | 特别地用于眼科手术的手术方法和用于染色蛋白质的染料分子和染料制备物 | |
| JP5489581B2 (ja) | プラノプロフェン含有水性組成物 | |
| CA2900671A1 (en) | Alpha-2 adrenergic agonist for treating intraocular pressure and ocular diseases through intravitreal and intracameral routes | |
| HK40050888A (en) | Pharmacological agents for treating ocular diseases | |
| CN113286788A (zh) | 使用单线态氧治疗近视和其他眼病症 | |
| WO2024218275A1 (en) | Liquid and solid compositions of imipridone derivatives | |
| WO2018221713A1 (ja) | 難水溶性成分可溶化ミセル及びそれを含有する液剤 | |
| MX2007014652A (en) | Compositions and methods of treating retinal disease |